National Cancer Institute (NCI): all 3,554 studies

Page 24 of 36. Open to participants first (334), then studies with results posted, then the rest; newest registration first within each.

• AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaWithdrawnNCT01105390Phase 2
• Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid MalignanciesCompletedNCT01096355Phase 1
• Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal MetastasesWithdrawnNCT01095523Phase 2
• Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade GliomaActive, not recruitingNCT01089101Phase 1/2
• Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaTerminatedNCT01088763Phase 1
• Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell TransplantationCompletedNCT01087294Phase 1
• Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191CompletedNCT01086709
• A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal CancersTerminatedNCT01086696Early Phase 1
• Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast CancerCompletedNCT01077453Phase 1
• Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaTerminatedNCT01076556Phase 1
• Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsCompletedNCT01076530Phase 1
• Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT01074411Phase 1
• RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By SurgeryTerminatedNCT01071564Phase 1
• Selumetinib and Cixutumumab in Treating Patients With Advanced Solid MalignanciesCompletedNCT01061749Phase 1
• A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the Mississippi Delta in Cervical Cancer ScreeningCompletedNCT01058148
• A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung AdenocarcinomaCompletedNCT01051934Phase 1
• A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and LymphomasCompletedNCT01051635Phase 1
• Azacitidine and Oxaliplatin In Treating Patients With Advanced Cancers Relapsed or Refractory to Any Platinum TherapyCompletedNCT01039155Phase 1
• Development and Validation of a Symptom Scale for Children With Chronic Graft-versus-Host DiseaseCompletedNCT01036958
• Refinement of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Via Cognitive Interviewing and Usability TestingCompletedNCT01031641
• A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell CancerCompletedNCT01021059Phase 1
• Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurrent Solid TumorsCompletedNCT01017640Phase 1
• Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi SarcomaCompletedNCT01016730Phase 1
• Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the LungTerminatedNCT01013831Phase 1
• Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver CancerCompletedNCT01008566Phase 1
• Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and LymphomaCompletedNCT00994500Phase 1
• A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS TumorsCompletedNCT00994071Phase 1
• Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00989651Phase 1
• Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent GlioblastomaCompletedNCT00979862Phase 1
• National Cancer Institute Food StudyCompletedNCT00978406
• Amplification of Merkel Cell Polyomavirus From Skin SwabsCompletedNCT00977990
• Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood DisordersTerminatedNCT00973804Phase 1
• Relationship of pAKT to Survival in Patients With Node-Positive Breast CancerCompletedNCT00965276
• Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate CancerCompletedNCT00956163Early Phase 1
• ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS TumorsCompletedNCT00946335Phase 1
• Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung CancerTerminatedNCT00937482Phase 1
• Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or LeukemiaTerminatedNCT00933985Phase 1
• Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to TreatmentCompletedNCT00929903Phase 1
• A Pilot Study to Explore Serum and Imaging Biomarkers in Patients With Spinal Cord CompressionCompletedNCT00928382
• A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced CancersCompletedNCT00926640Phase 1
• Natural History Study of HIV Acquired in Infancy or ChildhoodCompletedNCT00924365
• Natural History Study of Patients With Neurofibromatosis Type IActive, not recruitingNCT00924196
• Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional TrialCompletedNCT00924131
• An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ...CompletedNCT00924092Phase 1
• Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung CancerCompletedNCT00923884
• Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary ZygomycosisCompletedNCT00923832
• Gene Therapy Using Anti-CEA Cells to Treat Metastatic CancerTerminatedNCT00923806Phase 1
• Evaluation of Blood Vessel Formation in Endocrine TumorsCompletedNCT00923780
• Effect of Talactoferrin in Adults With Non-Small Cell Lung CancerCompletedNCT00923741Phase 1
• Informed Consent in Pediatric Cancer TrialsCompletedNCT00923650
• A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced MalignanciesCompletedNCT00923520Phase 1
• Pharmacokinetic Studies Participation SurveyCompletedNCT00923468
• Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 ReceptorTerminatedNCT00923390Phase 1
• Breast Stem Cells in Women at Average Risk and Increased Risk for Breast CancerCompletedNCT00923377
• Blood and Tissue Study of Patients in NIH Protocol 08-C-0800CompletedNCT00923325
• Part 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma)CompletedNCT00923169Phase 1
• An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated SkinCompletedNCT00923104
• The Natural History of Solid Organ Cancer Stem Cells (SOCSC)TerminatedNCT00923052
• Anal Cancer Screening StudyCompletedNCT00914537
• A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore AreaCompletedNCT00913757
• Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00906360Phase 1
• Facilitating Web-based Patient Decision Support: Decision About Medication to Lower Breast Cancer RiskCompletedNCT00906321Not applicable
• Cancer Risk in Organ Transplant Recipients and End-Stage Renal DiseaseCompletedNCT00904579
• Sun Exposure and Melanoma in Agricultural WorkersCompletedNCT00901966
• A Pilot for a Case-Control Study of Esophageal Squamous Cell Carcinoma in Western KenyaCompletedNCT00901173
• Study of a Polymorphism in Patients With Prostate CancerCompletedNCT00900185
• Study of 9cUAB30 in Healthy ParticipantsCompletedNCT00896974Phase 1
• EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth CancerTerminatedNCT00896961Not applicable
• Studying Different Formulations of SR13668 in Healthy VolunteersCompletedNCT00896207Phase 1
• Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous TherapyCompletedNCT00892736Phase 1
• Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryCompletedNCT00891072Phase 1
• Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyCompletedNCT00890747Phase 1
• Collection of Tissue Samples for Study of Multidrug ResistanceCompletedNCT00880503
• Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to TreatmentCompletedNCT00880282Phase 1
• Assessment of Screening Modalities for Gynecologic CancersCompletedNCT00879840
• GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by SurgeryActive, not recruitingNCT00878163Phase 1
• Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated ControlsActive, not recruitingNCT00867464
• Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous SystemCompletedNCT00867178Phase 1
• Premenopausal Hormone Concentrations in a Population of Women at Very Low Risk of Breast CancerCompletedNCT00860886
• A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young WomenCompletedNCT00858078
• GDC-0449 in Treating Young Patients With Medulloblastoma That is Recurrent or Did Not Respond to Previous TreatmentCompletedNCT00822458Phase 1
• Sunitinib Malate and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to ChemotherapyCompletedNCT00813423Phase 1
• Human Papillomavirus Epidemiology in NigeriaCompletedNCT00804466Not applicable
• Case-Control Study of Inflammatory Breast Cancer in North AfricaCompletedNCT00793390
• Community Cancer Centers Pilot Patient SurveyCompletedNCT00786656
• Diindolylmethane in Preventing Cancer in Healthy VolunteersCompletedNCT00784394Phase 1
• Follow-Up of Bladder Cancer Patients From the New England Study of Environment and HealthCompletedNCT00776178
• FAU in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00769288Phase 1
• Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin LymphomaActive, not recruitingNCT00740805Phase 1
• Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00735930Phase 1
• Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform NeurofibromasCompletedNCT00727233Phase 1
• Resveratrol in Healthy Adult ParticipantsCompletedNCT00721877Phase 1
• Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue SarcomaCompletedNCT00720174Phase 1
• T-Cell Project: Epidemiologic ComponentCompletedNCT00705809
• Decitabine and Bortezomib in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00703300Phase 1
• Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid TumorsTerminatedNCT00701298Phase 1
• Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple MyelomaCompletedNCT00693433Phase 1
• Bowman-Birk Inhibitor Concentrate in Healthy MenCompletedNCT00679094Phase 1
• Cixutumumab and Temsirolimus in Treating Patients With Locally Advanced or Metastatic CancerCompletedNCT00678769Phase 1
• AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor CancersCompletedNCT00678132Phase 1

← National Cancer Institute (NCI) overview and focus areas